Ryanodex 250 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26FM9T9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,011
Award facts
- Contract value 100% obligated
- $16,010.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $16,010.70 by the Defense Logistics Agency (DLA) on January 13, 2026, for the supply of Ryanodex 250 mg vials. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of February 4, 2026. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at up to $999,999,999.00 through December 2026.
The DLA Medical Supply Chain relies on AmerisourceBergen as a critical vendor for pharmaceutical procurement supporting military and veteran healthcare systems worldwide. Ryanodex, a dantrolene sodium formulation used primarily in the treatment of malignant hyperthermia, represents a specialized medical commodity within the company's extensive portfolio of brand-name and generic medications, vaccines, and medical supplies. AmerisourceBergen's federal contract awards consistently demonstrate its capability to fulfill open competition requirements across diverse therapeutic domains, positioning it as a key supplier for federal medical procurement needs.
Quick answers
Who was awarded contract SPE2DR26FM9T9?
SPE2DR26FM9T9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26FM9T9 worth?
The government has obligated $16,011 on SPE2DR26FM9T9.
Is contract SPE2DR26FM9T9 an order under another contract?
Yes. SPE2DR26FM9T9 is a delivery order under SPE2DR25D2211, an indefinite delivery contract.
Was contract SPE2DR26FM9T9 competed?
The extent of competition for SPE2DR26FM9T9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award